Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 5.22102284 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.22102284 |
3 | L-phenylalanine metabolic process (GO:0006558) | 4.95408076 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.95408076 |
5 | COPI coating of Golgi vesicle (GO:0048205) | 4.58080528 |
6 | Golgi transport vesicle coating (GO:0048200) | 4.58080528 |
7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.55633354 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 4.55159976 |
9 | regulation of cholesterol homeostasis (GO:2000188) | 4.40932044 |
10 | kynurenine metabolic process (GO:0070189) | 4.33917485 |
11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.29890353 |
12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.29446642 |
13 | complement activation, classical pathway (GO:0006958) | 4.27820135 |
14 | negative regulation of fibrinolysis (GO:0051918) | 4.26272862 |
15 | complement activation, alternative pathway (GO:0006957) | 4.17522424 |
16 | regulation of protein activation cascade (GO:2000257) | 4.09612231 |
17 | indole-containing compound catabolic process (GO:0042436) | 4.07689544 |
18 | indolalkylamine catabolic process (GO:0046218) | 4.07689544 |
19 | tryptophan catabolic process (GO:0006569) | 4.07689544 |
20 | sulfur amino acid catabolic process (GO:0000098) | 4.04684890 |
21 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.02675101 |
22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.98953581 |
23 | urea metabolic process (GO:0019627) | 3.97276107 |
24 | urea cycle (GO:0000050) | 3.97276107 |
25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.95573040 |
26 | protein carboxylation (GO:0018214) | 3.95573040 |
27 | cysteine metabolic process (GO:0006534) | 3.95498606 |
28 | COPII vesicle coating (GO:0048208) | 3.95335555 |
29 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.90124119 |
30 | regulation of complement activation (GO:0030449) | 3.86924924 |
31 | * positive regulation of nuclease activity (GO:0032075) | 3.85781089 |
32 | bile acid biosynthetic process (GO:0006699) | 3.83948660 |
33 | tryptophan metabolic process (GO:0006568) | 3.83854521 |
34 | complement activation (GO:0006956) | 3.83534072 |
35 | B cell receptor signaling pathway (GO:0050853) | 3.82931780 |
36 | negative regulation of cholesterol transport (GO:0032375) | 3.80758782 |
37 | negative regulation of sterol transport (GO:0032372) | 3.80758782 |
38 | regulation of fibrinolysis (GO:0051917) | 3.74632836 |
39 | germinal center formation (GO:0002467) | 3.73177089 |
40 | mannose metabolic process (GO:0006013) | 3.72649219 |
41 | high-density lipoprotein particle remodeling (GO:0034375) | 3.72519372 |
42 | glyoxylate metabolic process (GO:0046487) | 3.72240128 |
43 | intestinal cholesterol absorption (GO:0030299) | 3.71223845 |
44 | protein retention in ER lumen (GO:0006621) | 3.67520797 |
45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.61970911 |
46 | lysine catabolic process (GO:0006554) | 3.61935278 |
47 | lysine metabolic process (GO:0006553) | 3.61935278 |
48 | valine metabolic process (GO:0006573) | 3.60818104 |
49 | nitrogen cycle metabolic process (GO:0071941) | 3.58862292 |
50 | cellular modified amino acid catabolic process (GO:0042219) | 3.55439518 |
51 | * regulation of nuclease activity (GO:0032069) | 3.51218169 |
52 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 3.49098888 |
53 | regulation of triglyceride catabolic process (GO:0010896) | 3.47246570 |
54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.46726312 |
55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.45844194 |
56 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45844194 |
57 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.44802600 |
58 | homocysteine metabolic process (GO:0050667) | 3.41402568 |
59 | reverse cholesterol transport (GO:0043691) | 3.40273655 |
60 | * cellular response to unfolded protein (GO:0034620) | 3.33564217 |
61 | bile acid metabolic process (GO:0008206) | 3.28772055 |
62 | * ER-nucleus signaling pathway (GO:0006984) | 3.25991821 |
63 | positive regulation of histone deacetylation (GO:0031065) | 3.25227991 |
64 | acylglycerol homeostasis (GO:0055090) | 3.24876464 |
65 | triglyceride homeostasis (GO:0070328) | 3.24876464 |
66 | NIK/NF-kappaB signaling (GO:0038061) | 3.22348812 |
67 | plasma lipoprotein particle clearance (GO:0034381) | 3.21892614 |
68 | 4-hydroxyproline metabolic process (GO:0019471) | 3.21213908 |
69 | protein activation cascade (GO:0072376) | 3.20075889 |
70 | positive thymic T cell selection (GO:0045059) | 3.19695389 |
71 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.18442905 |
72 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.15737780 |
73 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.14222658 |
74 | phospholipid efflux (GO:0033700) | 3.14118046 |
75 | detection of bacterium (GO:0016045) | 3.13335313 |
76 | immunoglobulin mediated immune response (GO:0016064) | 3.11276290 |
77 | exocrine pancreas development (GO:0031017) | 3.10451172 |
78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.10397773 |
79 | * cellular response to topologically incorrect protein (GO:0035967) | 3.10335762 |
80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10148296 |
81 | negative regulation of cell killing (GO:0031342) | 3.10148296 |
82 | aromatic amino acid family metabolic process (GO:0009072) | 3.08462315 |
83 | thymic T cell selection (GO:0045061) | 3.06151781 |
84 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.06129277 |
85 | serine family amino acid catabolic process (GO:0009071) | 3.05169520 |
86 | coenzyme catabolic process (GO:0009109) | 3.04296214 |
87 | protein-lipid complex remodeling (GO:0034368) | 3.02212271 |
88 | macromolecular complex remodeling (GO:0034367) | 3.02212271 |
89 | plasma lipoprotein particle remodeling (GO:0034369) | 3.02212271 |
90 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.00705235 |
91 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00237406 |
92 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.99063702 |
93 | alpha-amino acid catabolic process (GO:1901606) | 2.96538475 |
94 | ethanol oxidation (GO:0006069) | 2.94491495 |
95 | positive regulation of lipid catabolic process (GO:0050996) | 2.92841122 |
96 | glutamate metabolic process (GO:0006536) | 2.90011972 |
97 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.90002535 |
98 | protein-lipid complex assembly (GO:0065005) | 2.89894417 |
99 | detection of other organism (GO:0098543) | 2.89442450 |
100 | glycine metabolic process (GO:0006544) | 2.89333445 |
101 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88232328 |
102 | * ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.88045563 |
103 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.87925117 |
104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.87925117 |
105 | * response to endoplasmic reticulum stress (GO:0034976) | 2.87627958 |
106 | plasma lipoprotein particle assembly (GO:0034377) | 2.86949258 |
107 | cellular response to virus (GO:0098586) | 2.86491546 |
108 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.86385044 |
109 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.86178212 |
110 | acute-phase response (GO:0006953) | 2.85636332 |
111 | tyrosine metabolic process (GO:0006570) | 2.83963577 |
112 | negative regulation of protein activation cascade (GO:2000258) | 2.83083422 |
113 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.82816471 |
114 | cytolysis (GO:0019835) | 2.82106029 |
115 | cellular amino acid catabolic process (GO:0009063) | 2.81494416 |
116 | bile acid and bile salt transport (GO:0015721) | 2.80543054 |
117 | negative regulation of lipid transport (GO:0032369) | 2.80463722 |
118 | benzene-containing compound metabolic process (GO:0042537) | 2.79453205 |
119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.72779437 |
120 | macrophage activation involved in immune response (GO:0002281) | 2.71306195 |
121 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.70306610 |
122 | regulation of histone H3-K27 methylation (GO:0061085) | 2.68614489 |
123 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67824237 |
124 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67824237 |
125 | modulation by symbiont of host immune response (GO:0052553) | 2.67824237 |
126 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67824237 |
127 | modulation by symbiont of host defense response (GO:0052031) | 2.67824237 |
128 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67824237 |
129 | response to muramyl dipeptide (GO:0032495) | 2.66386292 |
130 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.63449790 |
131 | response to type I interferon (GO:0034340) | 2.62682300 |
132 | type I interferon signaling pathway (GO:0060337) | 2.59320389 |
133 | cellular response to type I interferon (GO:0071357) | 2.59320389 |
134 | modulation by symbiont of host cellular process (GO:0044068) | 2.59289616 |
135 | negative regulation of viral release from host cell (GO:1902187) | 2.56545449 |
136 | activation of Rac GTPase activity (GO:0032863) | 2.56256660 |
137 | histone H3-K36 demethylation (GO:0070544) | 2.55860836 |
138 | regulation of superoxide anion generation (GO:0032928) | 2.53618792 |
139 | T cell selection (GO:0045058) | 2.51806978 |
140 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.51634437 |
141 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.49881677 |
142 | positive regulation of B cell differentiation (GO:0045579) | 2.49583807 |
143 | positive regulation of Rap GTPase activity (GO:0032854) | 2.49104456 |
144 | positive regulation of extracellular matrix organization (GO:1903055) | 2.47683450 |
145 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.47397700 |
146 | modulation by virus of host process (GO:0019054) | 2.47376930 |
147 | activation of MAPKKK activity (GO:0000185) | 2.47332326 |
148 | N-acetylneuraminate metabolic process (GO:0006054) | 2.46234413 |
149 | detection of external biotic stimulus (GO:0098581) | 2.45002368 |
150 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.44203495 |
151 | protein localization to endosome (GO:0036010) | 2.43509257 |
152 | defense response to protozoan (GO:0042832) | 2.42708693 |
153 | negative thymic T cell selection (GO:0045060) | 2.40875035 |
154 | response to laminar fluid shear stress (GO:0034616) | 2.40170662 |
155 | B cell homeostasis (GO:0001782) | 2.39860413 |
156 | proline biosynthetic process (GO:0006561) | 2.38101818 |
157 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.37793216 |
158 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.36348754 |
159 | response to peptidoglycan (GO:0032494) | 2.36055868 |
160 | negative regulation of cell size (GO:0045792) | 2.35106298 |
161 | regulation of extracellular matrix disassembly (GO:0010715) | 2.31187359 |
162 | myeloid dendritic cell differentiation (GO:0043011) | 2.30600946 |
163 | focal adhesion assembly (GO:0048041) | 2.30485547 |
164 | cell-substrate adherens junction assembly (GO:0007045) | 2.30485547 |
165 | response to protozoan (GO:0001562) | 2.29715426 |
166 | apoptotic process involved in morphogenesis (GO:0060561) | 2.29444127 |
167 | cellular extravasation (GO:0045123) | 2.28703455 |
168 | positive regulation of protein deacetylation (GO:0090312) | 2.28535116 |
169 | regulation of monocyte differentiation (GO:0045655) | 2.28233915 |
170 | regulation of early endosome to late endosome transport (GO:2000641) | 2.28034348 |
171 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.26821878 |
172 | regulation of leukocyte degranulation (GO:0043300) | 2.25522767 |
173 | embryonic process involved in female pregnancy (GO:0060136) | 2.24682798 |
174 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.24054726 |
175 | Peyers patch development (GO:0048541) | 2.22351442 |
176 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.22351442 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.94124235 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.98666623 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.70303744 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.86566248 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.20071428 |
6 | * MYC_22102868_ChIP-Seq_BL_Human | 3.13060503 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.05175005 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.99695159 |
9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.83540868 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.60869119 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.58321636 |
12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.52442117 |
13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.51892885 |
14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23917331 |
15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10790386 |
16 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.08197457 |
17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.05455718 |
18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04946199 |
19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.99306387 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.97018599 |
21 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86651248 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83236890 |
23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.81551101 |
24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80102632 |
25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79156447 |
26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78086825 |
27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74093636 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71603671 |
29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67753247 |
30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.67399785 |
31 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67100239 |
32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60675867 |
33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59506773 |
34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50612372 |
35 | MAF_26560356_Chip-Seq_TH1_Human | 1.50289411 |
36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.47403489 |
37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46324787 |
38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42655816 |
39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41631784 |
40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.39454269 |
41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39409158 |
42 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.38674762 |
43 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36460252 |
44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.35399122 |
45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35013905 |
46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34801815 |
47 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34724670 |
48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34134877 |
49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28790278 |
50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28444898 |
51 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28263227 |
52 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26419606 |
53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25159262 |
54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23609931 |
55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22982228 |
56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22901493 |
57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22527755 |
58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21850719 |
59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21820011 |
60 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21029221 |
61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20934861 |
62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18735056 |
63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18283956 |
64 | MYB_26560356_Chip-Seq_TH1_Human | 1.16590355 |
65 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16253476 |
66 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.16182584 |
67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16179845 |
68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16122307 |
69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15756394 |
70 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15066941 |
71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14337315 |
72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13020787 |
73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12668529 |
74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12155209 |
75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12013125 |
76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11959800 |
77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10059065 |
78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07923055 |
79 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07903349 |
80 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.07146740 |
81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.06196193 |
82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06181492 |
83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06022239 |
84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05769179 |
85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05276207 |
86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04490068 |
87 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03658514 |
88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03437182 |
89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03352463 |
90 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03170480 |
91 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03052961 |
92 | * MAF_26560356_Chip-Seq_TH2_Human | 1.02533165 |
93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02222084 |
94 | MYB_26560356_Chip-Seq_TH2_Human | 1.02075399 |
95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01860263 |
96 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01528181 |
97 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01305630 |
98 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01060088 |
99 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.00905362 |
100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99879505 |
101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99573457 |
102 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98639048 |
103 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97865230 |
104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97719410 |
105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97654455 |
106 | * P68_20966046_ChIP-Seq_HELA_Human | 0.95932274 |
107 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95024140 |
108 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94258753 |
109 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93736667 |
110 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92428034 |
111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92136300 |
112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91562244 |
113 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91107302 |
114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90033955 |
115 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.89641470 |
116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88563499 |
117 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88064805 |
118 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87874497 |
119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87714430 |
120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.86747353 |
121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86522446 |
122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86522446 |
123 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86454966 |
124 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.85895355 |
125 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85339700 |
126 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.85332958 |
127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84982921 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.62357326 |
2 | MP0005360_urolithiasis | 4.85834677 |
3 | MP0005365_abnormal_bile_salt | 4.61783633 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.78362249 |
5 | MP0005083_abnormal_biliary_tract | 3.25936405 |
6 | MP0003252_abnormal_bile_duct | 2.98381820 |
7 | MP0001666_abnormal_nutrient_absorption | 2.74634988 |
8 | MP0009840_abnormal_foam_cell | 2.71252663 |
9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.69780221 |
10 | MP0010329_abnormal_lipoprotein_level | 2.59468209 |
11 | MP0003300_gastrointestinal_ulcer | 2.45580112 |
12 | MP0003705_abnormal_hypodermis_morpholog | 2.40067004 |
13 | MP0003763_abnormal_thymus_physiology | 2.30171073 |
14 | MP0003303_peritoneal_inflammation | 2.19551195 |
15 | MP0005220_abnormal_exocrine_pancreas | 2.18870632 |
16 | MP0000609_abnormal_liver_physiology | 2.04118360 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.01547872 |
18 | MP0003195_calcinosis | 1.88261213 |
19 | MP0008260_abnormal_autophagy | 1.87048488 |
20 | MP0008961_abnormal_basal_metabolism | 1.86554601 |
21 | MP0003806_abnormal_nucleotide_metabolis | 1.81178174 |
22 | MP0005332_abnormal_amino_acid | 1.81153268 |
23 | MP0005387_immune_system_phenotype | 1.74738010 |
24 | MP0001790_abnormal_immune_system | 1.74738010 |
25 | MP0009333_abnormal_splenocyte_physiolog | 1.69494566 |
26 | MP0003183_abnormal_peptide_metabolism | 1.66906282 |
27 | MP0002118_abnormal_lipid_homeostasis | 1.66610897 |
28 | MP0003868_abnormal_feces_composition | 1.66055184 |
29 | MP0000685_abnormal_immune_system | 1.65286052 |
30 | MP0001800_abnormal_humoral_immune | 1.65215782 |
31 | MP0009643_abnormal_urine_homeostasis | 1.56884626 |
32 | MP0009785_altered_susceptibility_to | 1.55717908 |
33 | MP0002138_abnormal_hepatobiliary_system | 1.55282843 |
34 | MP0005319_abnormal_enzyme/_coenzyme | 1.51660125 |
35 | MP0001835_abnormal_antigen_presentation | 1.49186889 |
36 | MP0004264_abnormal_extraembryonic_tissu | 1.48750888 |
37 | MP0001944_abnormal_pancreas_morphology | 1.40515116 |
38 | MP0009278_abnormal_bone_marrow | 1.39444225 |
39 | MP0003453_abnormal_keratinocyte_physiol | 1.38624732 |
40 | MP0002396_abnormal_hematopoietic_system | 1.38024078 |
41 | MP0005076_abnormal_cell_differentiation | 1.33471573 |
42 | MP0003091_abnormal_cell_migration | 1.32582091 |
43 | MP0002148_abnormal_hypersensitivity_rea | 1.30852380 |
44 | MP0000858_altered_metastatic_potential | 1.30363302 |
45 | MP0005409_darkened_coat_color | 1.29613825 |
46 | MP0000678_abnormal_parathyroid_gland | 1.26974872 |
47 | MP0002693_abnormal_pancreas_physiology | 1.26523956 |
48 | MP0002405_respiratory_system_inflammati | 1.26402467 |
49 | MP0004947_skin_inflammation | 1.26238818 |
50 | MP0004185_abnormal_adipocyte_glucose | 1.25830398 |
51 | MP0005670_abnormal_white_adipose | 1.25436676 |
52 | MP0004510_myositis | 1.24569678 |
53 | MP0002722_abnormal_immune_system | 1.24115026 |
54 | MP0000598_abnormal_liver_morphology | 1.21610466 |
55 | * MP0003436_decreased_susceptibility_to | 1.20831850 |
56 | MP0002078_abnormal_glucose_homeostasis | 1.20424130 |
57 | MP0003656_abnormal_erythrocyte_physiolo | 1.18893683 |
58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18471188 |
59 | MP0001348_abnormal_lacrimal_gland | 1.17821570 |
60 | MP0002132_abnormal_respiratory_system | 1.14748442 |
61 | MP0009780_abnormal_chondrocyte_physiolo | 1.14367563 |
62 | MP0005058_abnormal_lysosome_morphology | 1.14362847 |
63 | MP0002452_abnormal_antigen_presenting | 1.12932042 |
64 | MP0004858_abnormal_nervous_system | 1.12696808 |
65 | MP0008438_abnormal_cutaneous_collagen | 1.12123111 |
66 | MP0003566_abnormal_cell_adhesion | 1.09673486 |
67 | MP0008469_abnormal_protein_level | 1.09226917 |
68 | MP0002909_abnormal_adrenal_gland | 1.08824961 |
69 | MP0002928_abnormal_bile_duct | 1.07820911 |
70 | MP0003172_abnormal_lysosome_physiology | 1.07444372 |
71 | MP0002998_abnormal_bone_remodeling | 1.06692785 |
72 | MP0001849_ear_inflammation | 1.06498475 |
73 | MP0001845_abnormal_inflammatory_respons | 1.06479694 |
74 | MP0000703_abnormal_thymus_morphology | 1.04316804 |
75 | MP0002723_abnormal_immune_serum | 1.02833989 |
76 | MP0000604_amyloidosis | 1.02413090 |
77 | MP0000003_abnormal_adipose_tissue | 1.01613287 |
78 | MP0010234_abnormal_vibrissa_follicle | 1.01104119 |
79 | MP0002796_impaired_skin_barrier | 0.98626543 |
80 | MP0002166_altered_tumor_susceptibility | 0.96815435 |
81 | MP0005464_abnormal_platelet_physiology | 0.94182368 |
82 | * MP0005000_abnormal_immune_tolerance | 0.92884927 |
83 | MP0002136_abnormal_kidney_physiology | 0.92850158 |
84 | MP0005334_abnormal_fat_pad | 0.91827191 |
85 | MP0001853_heart_inflammation | 0.91640864 |
86 | MP0009764_decreased_sensitivity_to | 0.90762518 |
87 | MP0001756_abnormal_urination | 0.90506320 |
88 | MP0010352_gastrointestinal_tract_polyps | 0.89856389 |
89 | MP0005636_abnormal_mineral_homeostasis | 0.89261210 |
90 | MP0005397_hematopoietic_system_phenotyp | 0.88889326 |
91 | MP0001545_abnormal_hematopoietic_system | 0.88889326 |
92 | MP0009642_abnormal_blood_homeostasis | 0.87803953 |
93 | MP0002089_abnormal_postnatal_growth/wei | 0.87685458 |
94 | MP0003866_abnormal_defecation | 0.86943581 |
95 | MP0005647_abnormal_sex_gland | 0.86728648 |
96 | MP0004381_abnormal_hair_follicle | 0.86435120 |
97 | MP0005023_abnormal_wound_healing | 0.86338069 |
98 | MP0004808_abnormal_hematopoietic_stem | 0.85784574 |
99 | MP0006054_spinal_hemorrhage | 0.84443456 |
100 | MP0005375_adipose_tissue_phenotype | 0.84024025 |
101 | MP0009931_abnormal_skin_appearance | 0.83637268 |
102 | MP0010155_abnormal_intestine_physiology | 0.83053590 |
103 | MP0005025_abnormal_response_to | 0.82516432 |
104 | MP0005448_abnormal_energy_balance | 0.82365130 |
105 | MP0002420_abnormal_adaptive_immunity | 0.81680138 |
106 | MP0005451_abnormal_body_composition | 0.81088026 |
107 | MP0002006_tumorigenesis | 0.80737543 |
108 | MP0000689_abnormal_spleen_morphology | 0.80324868 |
109 | MP0009763_increased_sensitivity_to | 0.80229836 |
110 | MP0008874_decreased_physiological_sensi | 0.80162807 |
111 | MP0004019_abnormal_vitamin_homeostasis | 0.80127542 |
112 | MP0001819_abnormal_immune_cell | 0.79099985 |
113 | MP0005621_abnormal_cell_physiology | 0.78633042 |
114 | MP0001873_stomach_inflammation | 0.78611617 |
115 | MP0000249_abnormal_blood_vessel | 0.77774769 |
116 | MP0002419_abnormal_innate_immunity | 0.77568900 |
117 | MP0004782_abnormal_surfactant_physiolog | 0.77127719 |
118 | MP0002398_abnormal_bone_marrow | 0.75643297 |
119 | MP0000716_abnormal_immune_system | 0.75304542 |
120 | MP0003959_abnormal_lean_body | 0.75110934 |
121 | MP0005310_abnormal_salivary_gland | 0.75074668 |
122 | MP0000013_abnormal_adipose_tissue | 0.74389412 |
123 | MP0001765_abnormal_ion_homeostasis | 0.72533877 |
124 | MP0002970_abnormal_white_adipose | 0.71774315 |
125 | MP0004043_abnormal_pH_regulation | 0.71214343 |
126 | MP0004130_abnormal_muscle_cell | 0.70423125 |
127 | MP0003045_fibrosis | 0.70301868 |
128 | MP0002933_joint_inflammation | 0.68818264 |
129 | MP0006082_CNS_inflammation | 0.64474743 |
130 | MP0005666_abnormal_adipose_tissue | 0.64298877 |
131 | MP0003075_altered_response_to | 0.63829768 |
132 | MP0002971_abnormal_brown_adipose | 0.63821068 |
133 | MP0005166_decreased_susceptibility_to | 0.63764977 |
134 | * MP0001533_abnormal_skeleton_physiology | 0.63569427 |
135 | MP0001764_abnormal_homeostasis | 0.62942325 |
136 | MP0002429_abnormal_blood_cell | 0.62745531 |
137 | MP0005671_abnormal_response_to | 0.62645502 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 5.08650756 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.71336705 |
3 | Xanthomatosis (HP:0000991) | 4.17733233 |
4 | Complement deficiency (HP:0004431) | 4.08499355 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.05426518 |
6 | Intrahepatic cholestasis (HP:0001406) | 4.03946756 |
7 | Agammaglobulinemia (HP:0004432) | 3.88193871 |
8 | Abnormality of the common coagulation pathway (HP:0010990) | 3.81404064 |
9 | Hypoglycemic coma (HP:0001325) | 3.64117065 |
10 | Prolonged partial thromboplastin time (HP:0003645) | 3.51503450 |
11 | Mitral stenosis (HP:0001718) | 3.51432200 |
12 | Ketosis (HP:0001946) | 3.50383982 |
13 | Abnormality of the intrinsic pathway (HP:0010989) | 3.45753826 |
14 | Hypobetalipoproteinemia (HP:0003563) | 3.31536686 |
15 | Colitis (HP:0002583) | 3.29235661 |
16 | Hyperlipoproteinemia (HP:0010980) | 3.24107571 |
17 | Cellulitis (HP:0100658) | 3.17595087 |
18 | Abnormality of complement system (HP:0005339) | 3.14246926 |
19 | Myocardial infarction (HP:0001658) | 3.13558632 |
20 | Eczematoid dermatitis (HP:0000976) | 3.06478809 |
21 | Verrucae (HP:0200043) | 3.03089534 |
22 | Papilloma (HP:0012740) | 3.03089534 |
23 | Ketoacidosis (HP:0001993) | 3.01586861 |
24 | Hypoglycemic seizures (HP:0002173) | 3.00600350 |
25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.89495357 |
26 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.87466691 |
27 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.87466691 |
28 | Fat malabsorption (HP:0002630) | 2.85123498 |
29 | Late onset (HP:0003584) | 2.83461805 |
30 | Increased IgE level (HP:0003212) | 2.78188314 |
31 | Joint hemorrhage (HP:0005261) | 2.73779448 |
32 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.73307197 |
33 | Gastrointestinal inflammation (HP:0004386) | 2.72620749 |
34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.71928262 |
35 | Inflammation of the large intestine (HP:0002037) | 2.60388615 |
36 | Hyperammonemia (HP:0001987) | 2.60088972 |
37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56681187 |
38 | Abnormality of macrophages (HP:0004311) | 2.56395422 |
39 | Hypolipoproteinemia (HP:0010981) | 2.55412460 |
40 | Mucopolysacchariduria (HP:0008155) | 2.52955765 |
41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52955765 |
42 | Obstructive sleep apnea (HP:0002870) | 2.52543821 |
43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.51300020 |
44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50033950 |
45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50033950 |
46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50033950 |
47 | Epidermoid cyst (HP:0200040) | 2.49691989 |
48 | Gout (HP:0001997) | 2.49076528 |
49 | Mediastinal lymphadenopathy (HP:0100721) | 2.47854007 |
50 | Recurrent bronchitis (HP:0002837) | 2.44468093 |
51 | Systemic lupus erythematosus (HP:0002725) | 2.42489488 |
52 | Flat acetabular roof (HP:0003180) | 2.42464375 |
53 | Vasculitis (HP:0002633) | 2.41393472 |
54 | Hypoalphalipoproteinemia (HP:0003233) | 2.39899608 |
55 | Abnormality of purine metabolism (HP:0004352) | 2.34267147 |
56 | Abnormality of the fingertips (HP:0001211) | 2.32446160 |
57 | Dysostosis multiplex (HP:0000943) | 2.29780870 |
58 | Gastrointestinal stroma tumor (HP:0100723) | 2.29481610 |
59 | Skin nodule (HP:0200036) | 2.28290168 |
60 | Recurrent viral infections (HP:0004429) | 2.27726587 |
61 | Thin bony cortex (HP:0002753) | 2.27509096 |
62 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.25335992 |
63 | Vertebral compression fractures (HP:0002953) | 2.24734127 |
64 | Restrictive lung disease (HP:0002091) | 2.23664165 |
65 | Symptomatic seizures (HP:0011145) | 2.23549184 |
66 | Conjugated hyperbilirubinemia (HP:0002908) | 2.17512393 |
67 | Gingival bleeding (HP:0000225) | 2.13750087 |
68 | Steatorrhea (HP:0002570) | 2.12227850 |
69 | Purpura (HP:0000979) | 2.11697539 |
70 | Panhypogammaglobulinemia (HP:0003139) | 2.10158185 |
71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.08830206 |
72 | Hyperglycinuria (HP:0003108) | 2.08119901 |
73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07577080 |
74 | Obstructive lung disease (HP:0006536) | 2.07577080 |
75 | Hypercholesterolemia (HP:0003124) | 2.05214344 |
76 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.04948992 |
77 | Back pain (HP:0003418) | 2.04906217 |
78 | Hyperglycemia (HP:0003074) | 2.02420644 |
79 | Recurrent sinusitis (HP:0011108) | 2.02414669 |
80 | Hyperglycinemia (HP:0002154) | 2.01843447 |
81 | Autoimmune thrombocytopenia (HP:0001973) | 2.00544753 |
82 | Protrusio acetabuli (HP:0003179) | 2.00325707 |
83 | Broad face (HP:0000283) | 2.00316521 |
84 | Abnormality of the Achilles tendon (HP:0005109) | 1.98905144 |
85 | Lymphopenia (HP:0001888) | 1.98833795 |
86 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.98352556 |
87 | Abnormality of glycine metabolism (HP:0010895) | 1.98352556 |
88 | Recurrent fungal infections (HP:0002841) | 1.97882255 |
89 | Recurrent bacterial skin infections (HP:0005406) | 1.97828845 |
90 | Recurrent abscess formation (HP:0002722) | 1.97431439 |
91 | Hyperbilirubinemia (HP:0002904) | 1.96994484 |
92 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.96688268 |
93 | Emphysema (HP:0002097) | 1.96570320 |
94 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.95186901 |
95 | Ulnar bowing (HP:0003031) | 1.94978889 |
96 | Reticulocytosis (HP:0001923) | 1.94271241 |
97 | Long toe (HP:0010511) | 1.93388799 |
98 | Recurrent lower respiratory tract infections (HP:0002783) | 1.92005903 |
99 | Sensorimotor neuropathy (HP:0007141) | 1.91189526 |
100 | Loss of speech (HP:0002371) | 1.90955389 |
101 | Osteomyelitis (HP:0002754) | 1.90761636 |
102 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89745739 |
103 | Hemorrhage of the eye (HP:0011885) | 1.89149279 |
104 | Abnormality of the thoracic spine (HP:0100711) | 1.88769662 |
105 | Hypertensive crisis (HP:0100735) | 1.88465335 |
106 | Protuberant abdomen (HP:0001538) | 1.88346368 |
107 | Achilles tendon contracture (HP:0001771) | 1.88123127 |
108 | Hypertriglyceridemia (HP:0002155) | 1.87424884 |
109 | J-shaped sella turcica (HP:0002680) | 1.86787996 |
110 | Interstitial pulmonary disease (HP:0006530) | 1.86185420 |
111 | Hepatocellular carcinoma (HP:0001402) | 1.85695651 |
112 | Cervical subluxation (HP:0003308) | 1.85526423 |
113 | Epistaxis (HP:0000421) | 1.84472237 |
114 | Cerebral aneurysm (HP:0004944) | 1.84260966 |
115 | Aneurysm (HP:0002617) | 1.84172259 |
116 | Cholecystitis (HP:0001082) | 1.83742788 |
117 | Abnormal gallbladder physiology (HP:0012438) | 1.83742788 |
118 | Menorrhagia (HP:0000132) | 1.83654945 |
119 | Polycythemia (HP:0001901) | 1.83328347 |
120 | Sepsis (HP:0100806) | 1.83185937 |
121 | Gingivitis (HP:0000230) | 1.82656449 |
122 | Increased serum ferritin (HP:0003281) | 1.81730443 |
123 | Glomerulonephritis (HP:0000099) | 1.81488681 |
124 | Easy fatigability (HP:0003388) | 1.81019756 |
125 | Recurrent pneumonia (HP:0006532) | 1.80084541 |
126 | Hyperacusis (HP:0010780) | 1.79407879 |
127 | Impaired platelet aggregation (HP:0003540) | 1.79314020 |
128 | Abnormal platelet function (HP:0011869) | 1.79314020 |
129 | Thoracic kyphosis (HP:0002942) | 1.77913644 |
130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76619250 |
131 | Meningitis (HP:0001287) | 1.76062468 |
132 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74501404 |
133 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.74495417 |
134 | Macroorchidism (HP:0000053) | 1.74188785 |
135 | Abnormality of B cell number (HP:0010975) | 1.73979245 |
136 | B lymphocytopenia (HP:0010976) | 1.73979245 |
137 | Pustule (HP:0200039) | 1.73441851 |
138 | Myositis (HP:0100614) | 1.72355297 |
139 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71769375 |
140 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71769375 |
141 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71769375 |
142 | Abnormality of the peritoneum (HP:0002585) | 1.71677907 |
143 | Insulin resistance (HP:0000855) | 1.71631292 |
144 | Esophageal varix (HP:0002040) | 1.71410400 |
145 | Polygenic inheritance (HP:0010982) | 1.70947045 |
146 | Hand muscle atrophy (HP:0009130) | 1.70631566 |
147 | Malnutrition (HP:0004395) | 1.70450154 |
148 | Distal upper limb amyotrophy (HP:0007149) | 1.70289849 |
149 | Upper limb amyotrophy (HP:0009129) | 1.70289849 |
150 | Skin rash (HP:0000988) | 1.70093329 |
151 | Biconcave vertebral bodies (HP:0004586) | 1.69963833 |
152 | Spontaneous hematomas (HP:0007420) | 1.68837972 |
153 | Long palpebral fissure (HP:0000637) | 1.68398975 |
154 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.67697830 |
155 | Nephritis (HP:0000123) | 1.67585039 |
156 | Gastrointestinal infarctions (HP:0005244) | 1.67533853 |
157 | Hydroxyprolinuria (HP:0003080) | 1.67442998 |
158 | Abnormality of proline metabolism (HP:0010907) | 1.67442998 |
159 | Ectopia lentis (HP:0001083) | 1.66928843 |
160 | Exocrine pancreatic insufficiency (HP:0001738) | 1.66807273 |
161 | Skin ulcer (HP:0200042) | 1.66169452 |
162 | Abdominal distention (HP:0003270) | 1.66086212 |
163 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.65495462 |
164 | Elevated alkaline phosphatase (HP:0003155) | 1.64459222 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K10 | 4.32614768 |
2 | TRIB3 | 4.01385664 |
3 | PRPF4B | 3.45909486 |
4 | SIK1 | 3.44619495 |
5 | MAP4K1 | 3.35624202 |
6 | BCKDK | 3.00208805 |
7 | SMG1 | 2.83244679 |
8 | TAOK3 | 2.81543806 |
9 | RIPK4 | 2.58702614 |
10 | * ERN1 | 2.57982316 |
11 | PKN2 | 2.49924256 |
12 | EEF2K | 2.47089707 |
13 | FGFR4 | 2.38156976 |
14 | CDK12 | 2.22295166 |
15 | PTK6 | 1.86442550 |
16 | INSRR | 1.78189967 |
17 | GRK6 | 1.73099010 |
18 | IRAK4 | 1.61696325 |
19 | EPHB1 | 1.58725209 |
20 | TYK2 | 1.55606397 |
21 | TBK1 | 1.54345291 |
22 | JAK1 | 1.40300490 |
23 | SIK2 | 1.38916085 |
24 | BTK | 1.30798944 |
25 | SIK3 | 1.28872564 |
26 | LRRK2 | 1.28108024 |
27 | MAP3K7 | 1.23915823 |
28 | ICK | 1.23458071 |
29 | EPHA3 | 1.20637838 |
30 | CSF1R | 1.20399434 |
31 | ZAP70 | 1.20076845 |
32 | SYK | 1.15678395 |
33 | ARAF | 1.15590040 |
34 | EPHA2 | 1.12688730 |
35 | FLT3 | 1.09843861 |
36 | MTOR | 1.09782546 |
37 | CAMK1D | 1.09566344 |
38 | TAOK2 | 1.08933090 |
39 | STK10 | 1.06221642 |
40 | HIPK2 | 1.02269897 |
41 | LATS1 | 1.02157559 |
42 | PIK3CG | 1.01688150 |
43 | CAMK1G | 1.01571656 |
44 | MAP3K3 | 1.01301889 |
45 | MAPK11 | 1.00087532 |
46 | PASK | 0.99916769 |
47 | PDGFRA | 0.99000015 |
48 | PRKCH | 0.98754815 |
49 | JAK3 | 0.98616947 |
50 | BLK | 0.98382384 |
51 | MST1R | 0.98321982 |
52 | CSK | 0.97093156 |
53 | TAOK1 | 0.92354250 |
54 | RIPK1 | 0.90819385 |
55 | MAP3K13 | 0.89351775 |
56 | TESK1 | 0.89253282 |
57 | DYRK1B | 0.89094056 |
58 | NME2 | 0.87693556 |
59 | JAK2 | 0.86999580 |
60 | BMX | 0.86839165 |
61 | MAPK15 | 0.84718213 |
62 | SCYL2 | 0.83161784 |
63 | BRD4 | 0.82524469 |
64 | IKBKE | 0.81844585 |
65 | IRAK3 | 0.78992750 |
66 | PTK2 | 0.76565295 |
67 | CHUK | 0.75821971 |
68 | FGFR3 | 0.75486207 |
69 | FRK | 0.72199549 |
70 | MAP3K1 | 0.71959799 |
71 | MAPKAPK3 | 0.71939286 |
72 | HCK | 0.70355461 |
73 | PRKD2 | 0.69002668 |
74 | IRAK2 | 0.66656035 |
75 | TGFBR2 | 0.65408921 |
76 | PIM2 | 0.62818379 |
77 | MAP3K8 | 0.62730539 |
78 | PRKD1 | 0.62540478 |
79 | CDC42BPA | 0.62314478 |
80 | MAP2K3 | 0.61943904 |
81 | CDK4 | 0.61728964 |
82 | MAP2K2 | 0.61721518 |
83 | KDR | 0.61638063 |
84 | MAP3K14 | 0.60981378 |
85 | ITK | 0.58642384 |
86 | PRKD3 | 0.57997737 |
87 | TTN | 0.56880736 |
88 | TESK2 | 0.56714568 |
89 | LYN | 0.55827772 |
90 | RET | 0.55798096 |
91 | DDR2 | 0.54625720 |
92 | BRAF | 0.53033891 |
93 | MAP3K11 | 0.52596823 |
94 | MARK2 | 0.52373998 |
95 | MATK | 0.52034711 |
96 | RPS6KC1 | 0.51993498 |
97 | RPS6KL1 | 0.51993498 |
98 | MAPKAPK2 | 0.51853456 |
99 | PAK2 | 0.49788964 |
100 | CDK9 | 0.48818178 |
101 | MAPK12 | 0.46789044 |
102 | RPS6KA4 | 0.45785741 |
103 | MARK3 | 0.45447139 |
104 | RPS6KA2 | 0.42633964 |
105 | KSR2 | 0.42591796 |
106 | PRKCI | 0.41985717 |
107 | FES | 0.41890443 |
108 | MAP3K2 | 0.41086080 |
109 | KIT | 0.41027485 |
110 | NEK9 | 0.40913147 |
111 | CDK6 | 0.40767104 |
112 | MAP2K1 | 0.40529171 |
113 | ALK | 0.39792812 |
114 | PRKAA1 | 0.39718373 |
115 | EGFR | 0.39630371 |
116 | IKBKB | 0.39114117 |
117 | CDK7 | 0.38780982 |
118 | MAP3K9 | 0.36630328 |
119 | MAPK7 | 0.36073798 |
120 | LCK | 0.36014220 |
121 | MAPK4 | 0.35807619 |
122 | TNK2 | 0.35711228 |
123 | PDK1 | 0.35564203 |
124 | PDPK1 | 0.35213653 |
125 | SGK3 | 0.34666675 |
126 | PDGFRB | 0.34516697 |
127 | EIF2AK3 | 0.33299418 |
128 | ABL1 | 0.33067386 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.78555194 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.52293995 |
3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.99574470 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.90019778 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.72268390 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58159678 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.46406514 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46230981 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13696919 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.03568448 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 1.94431090 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89124022 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.88088254 |
14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.83533490 |
15 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.82973173 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82180683 |
17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72453345 |
18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69152368 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.68584611 |
20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67465227 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65700753 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60680228 |
23 | Lysine degradation_Homo sapiens_hsa00310 | 1.59939124 |
24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57324439 |
25 | Asthma_Homo sapiens_hsa05310 | 1.51096834 |
26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49737153 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.45780439 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44500888 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41661868 |
30 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.39537807 |
31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38418023 |
32 | Bile secretion_Homo sapiens_hsa04976 | 1.37912706 |
33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36494502 |
34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.36016980 |
35 | Peroxisome_Homo sapiens_hsa04146 | 1.35567878 |
36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31754740 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30644975 |
38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30166555 |
39 | ABC transporters_Homo sapiens_hsa02010 | 1.27588121 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24214991 |
41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23154293 |
42 | Tuberculosis_Homo sapiens_hsa05152 | 1.23104493 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22636381 |
44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.22433271 |
45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20196319 |
46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18627976 |
47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17624476 |
48 | Insulin resistance_Homo sapiens_hsa04931 | 1.16201552 |
49 | Hepatitis C_Homo sapiens_hsa05160 | 1.15796965 |
50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14827193 |
51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13781624 |
52 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13384244 |
53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.09934466 |
54 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09358977 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 1.07462776 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06698509 |
57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.99772546 |
58 | Measles_Homo sapiens_hsa05162 | 0.98819629 |
59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97628889 |
60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94403636 |
61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92778541 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92358675 |
63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90756786 |
64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89688238 |
65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89034491 |
66 | Protein export_Homo sapiens_hsa03060 | 0.88756576 |
67 | Prion diseases_Homo sapiens_hsa05020 | 0.88303965 |
68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87818499 |
69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85205661 |
70 | Apoptosis_Homo sapiens_hsa04210 | 0.84644979 |
71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84521015 |
72 | Pertussis_Homo sapiens_hsa05133 | 0.83742667 |
73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83434359 |
74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82948346 |
75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81871798 |
76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81381233 |
77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80983494 |
78 | Prostate cancer_Homo sapiens_hsa05215 | 0.80092167 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78112208 |
80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77203962 |
81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76851698 |
82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75748846 |
83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73369513 |
84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73362245 |
85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73227090 |
86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71659429 |
87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70795392 |
88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69626494 |
89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69435317 |
90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68561592 |
91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68388081 |
92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66056890 |
93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65938452 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65540463 |
95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65237147 |
96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64799722 |
97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63681989 |
98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63634537 |
99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63617540 |
100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63277694 |
101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61361510 |
102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60289242 |
103 | Malaria_Homo sapiens_hsa05144 | 0.57891283 |
104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57511462 |
105 | Lysosome_Homo sapiens_hsa04142 | 0.57415817 |
106 | Amoebiasis_Homo sapiens_hsa05146 | 0.56976429 |
107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56864985 |
108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56535983 |
109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56234130 |
110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56139935 |
111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55689594 |
112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55401453 |
113 | Glioma_Homo sapiens_hsa05214 | 0.54248913 |
114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53785089 |
115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53645185 |
116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52676583 |
117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52512766 |
118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52242722 |
119 | Bladder cancer_Homo sapiens_hsa05219 | 0.51771415 |
120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50977140 |
121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50415458 |
122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50014654 |
123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48784601 |
124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48722725 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.48551018 |
126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46635870 |
127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45648395 |
128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43607422 |
129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42959074 |
130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42338418 |
131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41568779 |
132 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41198409 |
133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40615311 |
134 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40281412 |
135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39456274 |
136 | Leishmaniasis_Homo sapiens_hsa05140 | 0.39427676 |
137 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37946122 |
138 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36895048 |
139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36804768 |
140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35763042 |
141 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35666849 |
142 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34697982 |
143 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33700876 |
144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33171648 |
145 | Legionellosis_Homo sapiens_hsa05134 | 0.30318212 |
146 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.29120159 |
147 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29086901 |
148 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27425444 |
149 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26946426 |
150 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26745917 |
151 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26472601 |
152 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26460123 |